Xingtai Pukelai Technology CoRetatrutide
Ordered Retatrutide from Xingtai Pukelai Technology Co? Mail in a sample (US only) and let us test it for free.
Test my supplyXingtai Pukelai Retatrutide is a mixed purity record: identity held, but 99.3% and 98.67% purity misses pull confidence down. A later 99.9% result shows rebound; sparse batch identifiers remain the key evidence gap.
We investigated who actually operates Xingtai Pukelai Technology Co — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Xingtai Pukelai Technology Co rows.
Cancel anytime
About Xingtai Pukelai Technology Co test results from Finnrick
Xingtai Pukelai Technology Co is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 7 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Xingtai Pukelai Technology Co peptides in this dataset are Retatrutide (7 tests) and GHK-Cu (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 7 recent tests.
Ordered Retatrutide from Xingtai Pukelai Technology Co? Mail in a sample (US only) and let us test it for free.
Test my supply